COVID-19 Cure: Clinical Trial Starts At PGIMER Chandigarh
Dr Ram Vishwakarma, CSIR-IIIM Director and coordinator of a trial programme for use of Sepsivac in COVID-19 treatment, said that clinical trial has begun at PGIMER Chandigarh to position immunomodulator Sepsivac as a drug.
#Chandigarh #COVID19 #Coronavirus
